title: Is interleukin-17 a proatherogenic biomarker?
abstract: The importance of chronic inflammation in atherogenesis and cytokine involvement in all stages of atherosclerotic plaque development is now obvious. Our approach of the significant cytokines involved in atherogenesis or cardiovascular diseases is based on a correlation between clinical research and experiments on animal models. The contribution of IL-17 in atherogenesis remains controversial. In this study we investigated the role of IL-17 in cardiovascular diseases and in atherosclerosis associated with pathological aging. We performed a case-control study, enrolling subjects aged over 65 years in both groups. We included 40 patients with cardiovascular disorders and 10 healthy volunteers. IL-17 levels were measured in the serum of patients and healthy controls, along with serum total cholesterol and triglycerides. Significantly higher levels of IL-17 were obtained in patients compared to healthy controls (p<0.001). The level of this biomarker correlated significantly with two biochemical parameters - serum total cholesterol and triglycerides (the Pearson coefficient showed statistical significance, p=0.033, respectively p=0.043). We did not find any correlation between IL-17 and these two parameters in the control group. Our study is useful in understanding the physiopathological implications of IL-17 in the atherogenesis process. This could represent a starting point for future studies, including research regarding the therapeutic potential of IL-17 in pathological aging.
authors.affiliation: Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, România. kristymed@yahoo.com
authors.forename: Cristina-Sorina
authors.initials: CS
authors.lastname: Cătană
authors.forename: Victor
authors.initials: V
authors.lastname: Cristea
authors.forename: Nicolae
authors.initials: N
authors.lastname: Miron
authors.forename: Ioana Berindan
authors.initials: IB
authors.lastname: Neagoe
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D050197:Atherosclerosis / Q000097:blood / Q000209:etiology*; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D020381:Interleukin-17 / Q000097:blood / Q000502:physiology*; D008297:Male
chemical_list: D015415:Biomarkers; D020381:Interleukin-17